# Quinapril and Hydrochlorothiazide 20/12.5

NDC: 69097-829
Generic name: Quinapril and Hydrochlorothiazide 20/12.5
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160720

FDA application: ANDA201356

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- QUINAPRIL HYDROCHLORIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-829"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-829
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1de5420c-23d6-40c5-ba24-39143c0f90fb
